An experimental RNA treatment may help preserve lean mass during semaglutide-assisted weight loss. The finding comes from mice, so it does not establish a benefit for people.
What changed
Northwestern researchers reported that the combination reduced more fat and preserved more lean mass than semaglutide alone. The RNA treatment suppresses ZFP423, a gene involved in whether fat cells store energy or burn it as heat.
How strong is the evidence?
Animal research. The university describes a study published in PNAS. This brief is based on the institutional report; the full paper was not accessible for verification. Sample sizes were not reported in that account.
What remains uncertain
Human safety, effective dosing, and clinical outcomes are unknown. Lean mass is not the same as muscle strength or physical function. The researchers reported a related patent application.
Why it matters
Preserving function during weight loss is a useful research goal, especially in later life. This is an experimental direction, not a treatment recommendation or reason to change prescribed medication.
Source
Northwestern Medicine research report · September 21, 2026.
